FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)



Status:Completed
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:13 - 16
Updated:2/20/2019
Start Date:May 2014
End Date:January 2018

Use our guide to learn which trials are right for you!

FL3X: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes

The purpose of this study is to see if a behavioral intervention for adolescents with type 1
diabetes will improve adherence to T1D self-management activities and improve diabetes
outcomes. We expect the intervention to improve diabetes outcomes when compared to usual
care.

The FL3X Adaptive Intervention is designed to increase adherence to T1D self-management
including medical management (blood sugar testing and insulin dosing), diet, and physical
activity. FL3X relies on MI, and problem-solving skills training (PSST) as the basis for the
counseling strategy, and creates a coherent integration across three key components of 1)
behavior family systems therapy focused on family communications and teamwork; 2)
individualized diabetes education in response to knowledge gaps relevant to behavioral goal
attainment; and 3) use of currently available communications technology to support behavioral
goal attainment through participant-defined reminders and motivational boosters, and/or peer
support.

All FL3X intervention participants will receive "FL3X-Basic", which is the initial 3-month
intervention that includes 4 sessions (40-60 min), supplemented with short additional
contacts (via text, email, or web-based communication) as needed. Thereafter, applying
principles of adaptive interventions, based on a decision rule using A1c values measured at
defined intervals, participants are iteratively assigned to "FL3X-Check-in" or
"FL3X-Regular", both of which continue with MI and PSST for the underlying counseling
strategy. In FL3X-Check-in, participants who are doing well ("responders") will receive
minimal ongoing support to reinforce successful strategies through brief monthly "touch-base"
contacts. In FL3X-Regular, those who are "Regular-responders" will have a minimum of 3-4
in-person full-length sessions (40-60 min) over each 6-month interval, with additional brief
contacts as needed (e.g., text, voice, or internet). FL3X participants randomized to the
control group will receive usual care.

Inclusion Criteria:

- type 1 diabetes with duration at least 12 months

- between ages 12-16 years at registration

- poor glycemic control (A1c 8.0-13.0%)

- parent/guardian willing to also participate

- not planning on moving in the following 18 months

Exclusion Criteria:

- pregnant (if female)

- diabetes type 2 or gestational

- Pre-existing systemic chronic disease (drug abuse, cancer, certain psychiatric
conditions)
We found this trial at
2
sites
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
 1-513-636-4200 
Phone: 513-803-9200
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Aurora, Colorado 80045
Phone: 303-724-8478
?
mi
from
Aurora, CO
Click here to add this to my saved trials